A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering Treatment
A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering Treatment
Not yet recruiting · NCT07708181 · Registry updated 2026-07-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering Treatment | Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Not yet recruiting | Phase 2 | 2026-07-20 | NCT07708181 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 18 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||